Navigation Links
Telik Announces Initiation of Phase 1 Clinical Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets in Combination With Lenalidomide (Revlimid(R)) in Patients With Myelodysplastic Syndrome (MDS)
Date:1/25/2010

PALO ALTO, Calif., Jan. 25 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK) today announced the initiation of a Phase 1 clinical study to evaluate ezatiostat hydrochloride (TELINTRA, TLK199) tablets in combination with lenalidomide (Revlimid) in patients with Myelodysplastic Syndrome (MDS).

This Phase 1 trial is an open label, multicenter, dose escalation study of TELINTRA in combination with lenalidomide in patients with non-deletion (5q-) low to intermediate-1 risk MDS.  TELINTRA will be administered in escalating doses in combination with standard dose and schedule lenalidomide.

The study is designed to enroll up to 30 patients and the primary objectives are to assess the safety, tolerability and the maximum tolerated dose of TELINTRA in combination with lenalidomide.  The rationale for the study included non-overlapping toxicities and different mechanisms of action of each component of the combination.

Telik previously reported positive Phase 1 results from a multicenter, dose escalation study of ezatiostat hydrochloride (TELINTRA, TLK199) tablets in patients with Myelodysplastic Syndrome (MDS) in a leading peer reviewed journal, Blood, 25 June 2009; Vol. 113, No.26, pp. 6533-6540.  Positive results from a separate Phase 1-2A study in MDS patients involving an intravenous formulation of TELINTRA were published in the Journal of Hematology and Oncology, 13 May 2009; Vol. 2, No.10, pp. 20-32.

A Phase 2 Study is ongoing evaluating two different treatment regimens of Telintra in MDS patients, with results expected early this year. In addition, TELINTRA is also being evaluated in a Phase 2 randomized study for the treatment of patient
'/>"/>

SOURCE Telik, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Telik Announces Presentation of Preclinical Data on Dual Inhibitors of Aurora Kinases and VEGFR2
2. Telik Announces Preclinical Data Demonstrating Anti-Cancer Activity of Dual Inhibitors of Aurora Kinase and VEGFR2
3. Telik Announces Telintra Presentation at American Society of Hematology Annual Meeting
4. Telik Announces Initiation of Two Phase 2 Randomized TELINTRA Studies
5. Teliks Proteasome Inhibitor Program Meets a Preclinical Development Milestone
6. Telik Announces Presentation at ASCO Annual Meeting
7. Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets In Patients With Myelodysplastic Syndrome
8. Telik Announces Publication of Positive Phase 1-2a Results of a Multicenter Study of TELCYTA(R) in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer
9. Telik Announces Third Quarter 2009 Financial Results
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... INDIANAPOLIS , Oct. 30, 2014 Today ... published details of its long-standing technology transfer program to ... (MDR-TB). Begun in 2003, the effort included Lilly donating ... manufacturers in China , ... South Africa – all MDR-TB ...
(Date:10/27/2014)... 2014 La enfermedad del reflujo gastroesofágico ... es un problema importante para muchas personas en ... alimentos [2] y hábitos alimentarios [3] ... la GERD. Takeda ha desarrollado la aplicación móvil ... los síntomas del reflujo. (Foto: ...
(Date:10/27/2014)... last few weeks, Ebola has gone from a localized health concern ... crisis when a traveler to United States ... infected. While much of the cable news talk focused ... as electronic health records (EHRs), to help find, combat, and control ... Alison Diana fills in those gaps by explaining how ...
Breaking Medicine Technology:Lilly Shares Insights from Decade-Long Technology Transfer Experience 2Lilly Shares Insights from Decade-Long Technology Transfer Experience 3Lilly Shares Insights from Decade-Long Technology Transfer Experience 4Trate los síntomas del reflujo gracias a la Food4GERD App 2Trate los síntomas del reflujo gracias a la Food4GERD App 3Trate los síntomas del reflujo gracias a la Food4GERD App 4EHRs in the Age of Ebola: Discuss on InformationWeek 2EHRs in the Age of Ebola: Discuss on InformationWeek 3
... , NEW YORK, Dec. ... report is available in its catalogue: , Electrodes ... , http://www.reportlinker.com/p0164320/Electrodes-for-Medical-Devices---A-Global-Market-Perspective.html , Electrodes in electronic devices ... that are created by chemical reactions. Medical application areas ...
... ALTO, Calif., Dec. 2 Varian, Inc. (Nasdaq: VARI ) ... U.S. Securities and Exchange Commission its Annual Report on Form 10-K ... Report may be accessed through the Company,s web site at www.varianinc.com, ... in the table shown. Stockholders may receive a hard copy ...
Cached Medicine Technology:Reportlinker Adds Electrodes for Medical Devices - A Global Market Perspective 2Reportlinker Adds Electrodes for Medical Devices - A Global Market Perspective 3Reportlinker Adds Electrodes for Medical Devices - A Global Market Perspective 4Reportlinker Adds Electrodes for Medical Devices - A Global Market Perspective 5Reportlinker Adds Electrodes for Medical Devices - A Global Market Perspective 6Reportlinker Adds Electrodes for Medical Devices - A Global Market Perspective 7
(Date:10/30/2014)... October 30, 2014 Don Allred Insurance, ... health insurance plans for North Carolina residents, is excited ... in Burlington’s Holly Hill Mall. The new branch has ... already helping customers through all facets of the insurance ... Allred Insurance spokesman Scott Allred couldn’t be happier with ...
(Date:10/30/2014)... Five months after their expansion, the ... new branding and a website to accompany their recent ... Mepham’s promotion to name partner earlier this year, Hodgkinson ... Mepham’s name and better reflect their combined litigation expertise. ... decision to implement new branding reflects Hodgkinson Street Mepham’s ...
(Date:10/30/2014)... 2014 Paramount Rx, a full-service prescription ... efforts to help people save money through its innovative ... for prescription drugs in the new health care system, ... to bridge the relationship between consumers, businesses and the ... challenges people face today with medical costs is the ...
(Date:10/30/2014)... HealthDay Reporter , WEDNESDAY, Oct. 29, 2014 (HealthDay ... who also have certain heart problems may increase their odds ... , , The therapy in question is called androgen deprivation therapy ... male hormones to prevent the growth of cancer cells, according ... therapy was linked to triple the risk of heart-related death ...
(Date:10/30/2014)... Dennis Thompson HealthDay Reporter ... Ebola outbreak in Liberia -- one of three West African ... Health Organization officials said Wednesday. Dr. Bruce Aylward, WHO,s ... number of burials in Liberia and no increase in laboratory-confirmed ... push to tame the epidemic may be making some progress, ...
Breaking Medicine News(10 mins):Health News:Allred Insurance Satellite Office Grand Opening 2Health News:Hodgkinson Street Mepham Rebrands 2Health News:Paramount Rx Discount Card Program Provides Valuable Resources in Midst of Current Health Care Reform 2Health News:Paramount Rx Discount Card Program Provides Valuable Resources in Midst of Current Health Care Reform 3Health News:Hormone Therapy May Up Heart-Related Deaths in Some Prostate Cancer Patients 2Health News:Hormone Therapy May Up Heart-Related Deaths in Some Prostate Cancer Patients 3Health News:Ebola Outbreak in Liberia May Be Slowing: WHO 2Health News:Ebola Outbreak in Liberia May Be Slowing: WHO 3
... ... and Research (CDER) will soon initiate a major enforcement initiative against cosmetics product ... L. England, former 17-year FDA veteran and FDAImports.com, LLC Founder. ... (Vocus) ...
... A ... Officers Association as the 2010 Health Leader of the Year. This is a distinction ... the health of the American people and that of the larger global community. ... San Diego, CA (PRWEB) May ...
... ... It,s 501(c)(3) application is filed, it has a bank account, and it even has ... What it needs now is a logo, and it has launched a nationwide ... The Spice House, singer Gretchen Wilson, and writer Michael Z. Williamson. , ...
... PITTSBURGH, May 23 Young women of reproductive-age are among ... have suggested that during pregnancy women are even more susceptible ... a time when men also are at greater risk. In ... and pregnant. The results were presented today at ...
... ... Moschetti’s collection , ... (Vocus) May 23, 2010 -- Readers will be struck by the illuminative work of a ... of the Prisoner. True to its name, this reflective anthology reveals the profound emotions and ...
... KitPackers®, ... This agreement provides the 3MTM Industrial Adhesives and Tapes Division with custom modification and ... such as epoxies, acrylics, urethanes, and premixed and frozen. , ... Germantown, WI (PRWEB) May 23, ...
Cached Medicine News:Health News:FDA to Take Up Major Enforcement Action Against Cosmetics Manufacturers With Illegal “Anti-Aging” Labeling Claims, According to FDAImports.com, LLC 2Health News:FDA to Take Up Major Enforcement Action Against Cosmetics Manufacturers With Illegal “Anti-Aging” Labeling Claims, According to FDAImports.com, LLC 3Health News:FDA to Take Up Major Enforcement Action Against Cosmetics Manufacturers With Illegal “Anti-Aging” Labeling Claims, According to FDAImports.com, LLC 4Health News:Health Leader of the Year for 2010 - U.S. Senator Daniel K. Inouye 2Health News:Health Leader of the Year for 2010 - U.S. Senator Daniel K. Inouye 3Health News:Health Leader of the Year for 2010 - U.S. Senator Daniel K. Inouye 4Health News:Art Contest for New Charity With A History 2Health News:Art Contest for New Charity With A History 3Health News:Art Contest for New Charity With A History 4Health News:Pregnancy doubles HIV risk in men; first trial of a microbicide in pregnant women 2Health News:Pregnancy doubles HIV risk in men; first trial of a microbicide in pregnant women 3Health News:Pregnancy doubles HIV risk in men; first trial of a microbicide in pregnant women 4Health News:The Heart of the Prisoner Revealed 2Health News:KitPackers Offers 3MTM Repackaging Capability 2
... Rusch Snap-Light™ laryngoscope blades are designed with ... fiber optic bundle can be removed to ... to reach areas. Our unique snap-on mechanism ... bright focused blades are interchangeable with other ...
... high quality fiberoptic system designed to meet ... fiberoptic laryngoscopes. The green color coding identifies ... to interconnect with other green coded systems. ... bright and focused light. The Greenspec pivot ...
Rigid plastic. Single use. Non-Sterile. The disposable laryngoscope blade that fits on a standard handle. Made of extremely rigid plastic. Bright white light out-performs metal blades. Single patient...
... Laryngoscopes are a high quality fiberoptic system ... greater standardization to fiberoptic laryngoscopes. The green ... indicates it's ability to interconnect with other ... offers a cool, bright and focused light. ...
Medicine Products: